Lactobacillus rhamnosus gg
Lactobacillus rhamnosus gg has been studied in 1 paper since 2022: 1 trial in people. The newest paper, Sep 28, 2022: “The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults”.
1 paper studies it2 findingsUpdated
“A decrease in the relative abundance of the genus Prevotella and Dehalobacterium in response to LGG supplementation in the MCI group was correlated with an improved cognitive score.”
- 1 lab in 1 country
- Human trial1
What did studies of Lactobacillus rhamnosus gg find?
2Studies of Lactobacillus rhamnosus gg measured 2 outcomes; the most studied are Dehalobacterium relative abundance (1 study) and Prevotella relative abundance (1).
Dehalobacterium relative abundance
downin humans1
1 study
Dehalobacterium relative abundance
downin humans1
Lactobacillus rhamnosus gg decreases Dehalobacterium relative abundance in humans.
“A decrease in the relative abundance of the genus Prevotella and Dehalobacterium in response to LGG supplementation in the MCI group was correlated with an improved cognitive score.”
Human trialmild cognitive impairmentthree-monthn = 169
Clinical nutrition (Edinburgh, Scotland)
Prevotella relative abundance
downin humans1
1 study
Prevotella relative abundance
downin humans1
Lactobacillus rhamnosus gg decreases Prevotella relative abundance in humans.
“A decrease in the relative abundance of the genus Prevotella and Dehalobacterium in response to LGG supplementation in the MCI group was correlated with an improved cognitive score.”
Human trialmild cognitive impairmentthree-monthn = 169
Clinical nutrition (Edinburgh, Scotland)